Aprotinin binding to amyloid fibrils

European Journal of Biochemistry

Volumn 267, Issue 8, 2000, Pages 2307-2311

  Cardoso, Isabel ^a   Barbosa Pereira, Pedro J ^b,d   Damas, Ana M ^a,c   Saraiva, Maria J M ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c UNIVERSITY OF PORTO   (Portugal)

^d INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

Amyloid fibrils; Aprotinin; Spermadhesin; Transthyretin

Indexed keywords

ADHESIN; AMYLOID; AMYLOID BETA PROTEIN; APROTININ; INSULIN; PREALBUMIN; RADIOPHARMACEUTICAL AGENT; SOYBEAN TRYPSIN INHIBITOR; TRANSYLOL;

AMYLOIDOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG PROTEIN BINDING; DRUG STRUCTURE; ELECTRICITY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION;

AMYLOID; ANIMALS; APROTININ; BINDING, COMPETITIVE; BIOLOGICAL MARKERS; BIOTINYLATION; GLYCOPROTEINS; INSULIN; IODINE RADIOISOTOPES; MICROFIBRILS; MODELS, MOLECULAR; MUTATION; PREALBUMIN; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SEMINAL VESICLE SECRETORY PROTEINS;

GLYCINE MAX;

EID: 0034054411     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01237.x     Document Type: Article

References (20)

1. 1. Teplow, D.B. (1998) Structural and kinetic features of amyloid β-protein fibrillogenesis. Amyloid: Int. J. Exp. Clin. Invest. 5, 121-142.
2. 2. Campistol, J.M., Shirahama, T., Abraham, C.R., Rodgers, O.G., Sole, M., Cohen, A.S. & Skinner, M. (1992) Demonstration of plasma proteinase inhibitors in beta 2-microglobulin amyloid deposits. Kidney Int. 42, 915-923.
3. 3. Aprile, C., Marinone, G., Saponato, R., Bonino, C. & Merlini, G. (1995) Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labeled aprotinin. Eur. J. Nucleic Med. 22, 1393-1401.
4. 4. Bianchi, C., Donadio, C., Tramonti, G., Lorusso & Bellitto, F. (1984) 99m Tc-aprotinin: a new tracer for kidney morphology and function. Eur. J. Nucleic Med. 9, 257-260.
5. 5. Furuya, H., Saraiva, M.J., Gawinowicz, M.A., Alves, I.L., Costa, P.P., Sasaki, H., Goto, I. & Sakaki, Y. (1991) Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP). Biochemistry 30, 2415-2421.
6. 6. Colon, W. & Kelly, J.W. (1992) Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31, 8654-8660.
7. 7. Bourke, M.J. & Rougvie, M.A. (1972) Cross-protein structures. I. Insulin fibrils. Biochemistry 11, 2435-2439.
8. 8. Eulitz, M., Breurer, M. & Linke, R.P. (1987) Is the formation of AL-type amyloid promoted by structural peculiarities of immunoglobulin L-chains? Primary structure of an amyloidogenic lambda-L-chain (BJP-ZIM). Biol. Chem Hoppe Seyler 368, 863-870.
9. 9. Billingsley, M.L., Pennypacker, K.R., Hoover, C.G., Brigati, D.J. & Kincaid, R.L. (1985) A rapid and sensitive method for detection and quantification of calcineurin and calmodulin-binding proteins using biotinylated calmodulin. Proc. Natl Acad. Sci. USA 82, 7585-7589.
10. 10. Eulitz, M. & Linke, R.P. (1982) Primary structure of the variable part of an amyloidogenic Bence-Jones Protein (Mev.). An unusual insertion in the third hypervariable region of a human Kappa-immunoglobulin light chain. Hoppe Seylers Z Physiol Chem. 363, 1347-1358.
11. 11. Calvete, J.J., Mann, K., Schäfer, W., Raida, M., Sanz, L. & Töpfer-Petersen, E. (1995) Boar spermadhesin PSP-II: location of posttranslational modifications, heterodimer formation with PSP-I glycoforms and effect of dimerization on the ligand capabilities of the subunits. FEBS Lett. 365, 179-182.
12. 12. Varela, P.F., Romero, A., Sanz, L., Romão, M.J., Töpfer-Petersen, E. & Calvete, J.J. (1997) The 2.4 Å resolution crystal structure of boar seminal plasma PSP-I/PSP-II: a zona pellucida-binding glycoprotein heterodimer of the spermadhesin family built by a CUB domain architecture. J. Mol. Biol. 274, 635-649.
13. 13. Van Jaarsveld, P.P., Edelhoch, H., Goodman, D.S. & Robbins, J. (1973) The interaction of human plasma retinol-binding protein and prealbumin. J. Biol. Chem. 548, 4698-4705.
14. 14. Fritz, H. & Wunderer, G. (1983) Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Drug Res. 33, 479-494.
15. 15. LeVine, H. (1995) Thioflavin T interaction with amyloid β-sheet structures. Amyloid: Int. J. Exp. Clin. Invest. 2, 1-6.
16. 16. Evans, S.V. (1993) SETOR: hardware-lighted three-dimensional solid model representations of macromolecules. J. Mol. Graphics 11, 127-128.
17. 17. Blake, C. & Serpell, L. (1996) Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuos beta-sheet helix. Structure 4, 989-998.
18. 18. Sebastião, M.P., Saraiva, M.J. & Damas, A.M. (1998) The crystal structure of amyloidogenic leu55→pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J. Biol. Chem. 273, 24715-24722.
19. 19. Inoue, S., Kuroiwa, M., Saraiva, M.J., Guimarães, A. & Kisilevsky, R. (1998) Ultrastructure of familial amyloid polyneuropathy amyloid fibrils: examination with high-resolution electron microscopy. J. Struct. Biol. 124, 1-12.
20. 20. Lansbury, P.T. Jr, Costa, P.R., Griffiths, J.M., Simon, E.J., Auger, M., Halverson, K.J., Kocisko, D.A., Hendsch, Z.S., Ashburn, T.T., Spencer, R.G.S., Tidor, B. & Griffin, R.G. (1995) Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat. Struct. Biol. 2, 990-998.